RUBINA HEMANI: Open Payments
NPI 1336522572 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 10 payments from 5 companies in 2025. Trend: 2023 $438 · 2024 $66 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $82 |
| Corium, LLC | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: VRAYLAR, Azstarys, REXULTI, INGREZZA, COBENFY.
Industry payments across FL — which companies pay providers there.
